Literature DB >> 14604759

Control of neuronal nitric oxide synthase and brain-derived neurotrophic factor levels by GABA-A receptors in the developing rat cortex.

A Mantelas1, A Stamatakis, I Kazanis, H Philippidis, F Stylianopoulou.   

Abstract

Gamma-aminobutyric acid (GABA) plays an important morphogenetic role, acting through GABA-A receptors, which are depolarizing in the developing rat brain. Other molecules with major morphogenetic roles are the nitric oxide free radical (NO(.)) and brain-derived neurotrophic factor (BDNF), both of which are involved in the control of synaptic plasticity and apoptosis. In the present work, we investigated the effect of GABA-A receptor activation on neuronal NO(.) synthase (nNOS) and BDNF immunoreactivity in the developing cortex of 5-day-old rats. We also determined the effect of GABA-A receptor activation on phosphorylated cAMP-response element binding protein (pCREB) immunoreactivity in an effort to elucidate the molecular mechanisms involved. Our results show that activation of GABA-A receptors leads to increased numbers of nNOS, BDNF and pCREB, as well as nNOS-pCREB and BDNF-pCREB doubly immunopositive cells. This effect is abolished when L-type Ca(2+) channels are blocked. These results indicate that the following mechanism could be operating: depolarization following GABA-A receptor activation leads to opening of L-type voltage-gated calcium channels, resulting in an increased Ca(2+) influx, which in turn leads to phosphorylation and, thus, activation, of the transcription factor CREB; the phosphorylated CREB can then induce BDNF, as well as nNOS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14604759     DOI: 10.1016/j.devbrainres.2003.08.001

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  9 in total

Review 1.  GABA receptor-mediated effects in the peripheral nervous system: A cross-interaction with neuroactive steroids.

Authors:  Valerio Magnaghi; Marinella Ballabio; Antonio Consoli; Jeremy J Lambert; Ilaria Roglio; Roberto C Melcangi
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  An enteroendocrine cell-based model for a quiescent intestinal stem cell niche.

Authors:  I R Radford; P N Lobachevsky
Journal:  Cell Prolif       Date:  2006-10       Impact factor: 6.831

3.  Calcium-dependent dephosphorylation of brain mitochondrial calcium/cAMP response element binding protein (CREB).

Authors:  Rosemary A Schuh; Tibor Kristián; Gary Fiskum
Journal:  J Neurochem       Date:  2005-01       Impact factor: 5.372

4.  Immature hippocampal neuronal networks do not develop tolerance to the excitatory actions of ethanol.

Authors:  Rafael Galindo; C Fernando Valenzuela
Journal:  Alcohol       Date:  2006-10       Impact factor: 2.405

5.  Liposome-entrapped GABA modulates the expression of nNOS in NG108-15 cells.

Authors:  Gisele C Vaz; Neeru M Sharma; Hong Zheng; Matthew C Zimmerman; Robson S Santos; Frederic Frezard; Marco A P Fontes; Kaushik P Patel
Journal:  J Neurosci Methods       Date:  2016-08-11       Impact factor: 2.390

6.  GABA and neuroactive steroid interactions in glia: new roles for old players?

Authors:  Valerio Magnaghi
Journal:  Curr Neuropharmacol       Date:  2007-03       Impact factor: 7.363

7.  The neurosteroid allopregnanolone modulates specific functions in central and peripheral glial cells.

Authors:  Alessandro Faroni; Valerio Magnaghi
Journal:  Front Endocrinol (Lausanne)       Date:  2011-12-28       Impact factor: 5.555

8.  Early depolarizing GABA controls critical-period plasticity in the rat visual cortex.

Authors:  Gabriele Deidda; Manuela Allegra; Chiara Cerri; Shovan Naskar; Guillaume Bony; Giulia Zunino; Yuri Bozzi; Matteo Caleo; Laura Cancedda
Journal:  Nat Neurosci       Date:  2014-12-08       Impact factor: 24.884

9.  The Importance of L-Arginine:NO:cGMP Pathway in Tolerance to Flunitrazepam in Mice.

Authors:  Sylwia Talarek; Joanna Listos; Jolanta Orzelska-Gorka; Malgorzata Jakobczuk; Jolanta Kotlinska; Grazyna Biala
Journal:  Neurotox Res       Date:  2016-12-12       Impact factor: 3.911

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.